Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats
Boehringer Ingelheim puts patient needs first as reflected in the results of the latest “PatientView” survey Boehringer Ingelheim puts patient needs first as reflected in the results of the latest “PatientView” survey Boehringer Ingelheim puts patient needs first as reflected in the results of the latest “PatientView” survey
Making More Health Together 2021: Creating sustainable health solutions for 50 million people in vulnerable communities Making More Health Together 2021: Creating sustainable health solutions for 50 million people in vulnerable communities Making More Health Together 2021: Creating sustainable health solutions for 50 million people in vulnerable communities
Boehringer Ingelheim shares updated 2030 environmental sustainability commitments Boehringer Ingelheim shares updated 2030 environmental sustainability commitments Boehringer Ingelheim shares updated 2030 environmental sustainability commitments
Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data
Boehringer Ingelheim Launches University of Medicine Excellence Boehringer Ingelheim Launches University of Medicine Excellence Boehringer Ingelheim Launches University of Medicine Excellence
First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
History Video History Video Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim.
Living Independence Living Independence Boehringer Ingelheim’s corporate culture is based on values that have been applied since the foundation of the company in 1885.
Flood disaster in Germany: donation increased to EUR 1 million Flood disaster in Germany: donation increased to EUR 1 million Flood disaster in Germany: donation increased to EUR 1 million
Looking after Bernard Brain: The impact of multiple health conditions on mental health such as depression Looking after Bernard Brain: The impact of multiple health conditions on mental health such as depression Looking after Bernard Brain: The impact of multiple health conditions on mental health such as depression
ATM Index: Ranking Progress & Focus on Early-Phase R&D ATM Index: Ranking Progress & Focus on Early-Phase R&D ATM Index: Ranking Progress & Focus on Early-Phase R&D
Award: Boehringer Ingelheim is Global Top Employer 2021 Award: Boehringer Ingelheim is Global Top Employer 2021 Award: Boehringer Ingelheim is Global Top Employer 2021
Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D
Boehringer Ingelheim: Digital Lab BI X Facilitates Global Partnerships Boehringer Ingelheim: Digital Lab BI X Facilitates Global Partnerships Boehringer Ingelheim: Digital Lab BI X Facilitates Global Partnerships
Successful IT transformation recognized: Boehringer Ingelheim wins Digital Leader Award 2020 Successful IT transformation recognized: Boehringer Ingelheim wins Digital Leader Award 2020 Successful IT transformation recognized: Boehringer Ingelheim wins Digital Leader Award 2020